Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 69.00
+3.20 (4.86%)
May 29, 2026, 1:30 PM CST
Tien Liang BioTech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 6.35 | -10.25 | 11.7 | 17.73 | 59.48 | 46.61 |
Depreciation & Amortization | 10.48 | 9.9 | 9.15 | 10.44 | 10.76 | 11.97 |
Other Amortization | 0.18 | 0.18 | 0.16 | 0.11 | 0.29 | 0.46 |
Loss (Gain) From Sale of Assets | -0.05 | -0.05 | 0.68 | -0.57 | -0.03 | - |
Loss (Gain) From Sale of Investments | - | - | -2.93 | - | - | - |
Other Operating Activities | -12.29 | -5.73 | -7.72 | -0.66 | -0.02 | 2.23 |
Change in Accounts Receivable | -35.17 | -16.22 | -0.73 | 15.42 | -3.4 | -4.69 |
Change in Inventory | -2.68 | -8.55 | 17.31 | 19.17 | -34.02 | -8.37 |
Change in Accounts Payable | 25.83 | 32.89 | 10.96 | -1.2 | -8.91 | 6.29 |
Change in Unearned Revenue | - | - | - | - | - | -2.89 |
Change in Other Net Operating Assets | 23.33 | 17.07 | 10.09 | 9.23 | -2.27 | -6.4 |
Operating Cash Flow | 15.97 | 19.23 | 48.66 | 69.67 | 21.88 | 45.21 |
Operating Cash Flow Growth | -63.88% | -60.48% | -30.16% | 218.42% | -51.60% | - |
Capital Expenditures | -32.11 | -23.19 | -4.05 | -4.96 | -1.01 | -0.6 |
Sale of Property, Plant & Equipment | 0.05 | 0.05 | 3.84 | 0.6 | 0.1 | - |
Sale (Purchase) of Intangibles | -0.13 | -0.13 | -0.1 | -0.38 | - | - |
Investment in Securities | -117.18 | -274.16 | -300.13 | - | - | - |
Other Investing Activities | 23.61 | 15.72 | -0.1 | -0.03 | -0.3 | -0.58 |
Investing Cash Flow | -125.75 | -281.71 | -300.53 | -4.78 | -1.21 | -1.18 |
Short-Term Debt Issued | - | 328.63 | 380 | - | - | - |
Total Debt Issued | 208.63 | 328.63 | 380 | - | - | - |
Short-Term Debt Repaid | - | -65.63 | -115 | -30 | -30.5 | -40 |
Long-Term Debt Repaid | - | -0.38 | -0.5 | -0.52 | -0.8 | -0.8 |
Total Debt Repaid | -65.88 | -66 | -115.5 | -30.52 | -31.3 | -40.8 |
Net Debt Issued (Repaid) | 142.75 | 262.62 | 264.5 | -30.52 | -31.3 | -40.8 |
Common Dividends Paid | - | - | -22.88 | - | - | - |
Other Financing Activities | -9.22 | -8.5 | -1.3 | - | - | - |
Financing Cash Flow | 133.53 | 254.12 | 240.32 | -30.52 | -31.3 | -40.8 |
Net Cash Flow | 23.74 | -8.36 | -11.55 | 34.37 | -10.63 | 3.23 |
Free Cash Flow | -16.14 | -3.96 | 44.61 | 64.71 | 20.87 | 44.61 |
Free Cash Flow Growth | - | - | -31.05% | 210.05% | -53.22% | - |
Free Cash Flow Margin | -2.72% | -0.77% | 11.58% | 14.07% | 3.95% | 7.81% |
Free Cash Flow Per Share | -0.35 | -0.09 | 0.97 | 1.41 | 0.46 | 0.97 |
Cash Interest Paid | 10.85 | 10.85 | 2.89 | 2.1 | 1.69 | 1.8 |
Cash Income Tax Paid | 0.13 | 0.13 | 0.82 | 0.06 | 0.01 | -0 |
Levered Free Cash Flow | -23.58 | -8.35 | 52.22 | 56.67 | -4.55 | 20.7 |
Unlevered Free Cash Flow | -16.18 | -1.39 | 54.15 | 57.97 | -3.44 | 21.86 |
Change in Working Capital | 11.31 | 25.19 | 37.62 | 42.62 | -48.6 | -16.05 |